A randomized phase II study of three fludarbine/antibody combinations for patients with symptomatic previously untreated chronic lymphocytic leukemia
Phase of Trial: Phase II
Latest Information Update: 04 Oct 2007
At a glance
- Drugs Antibodies; Fludarabine
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 04 Oct 2007 New trial record.